Dexmedetomidine for electrical storm in the ICU
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if a medication called dexmedetomidine (a sedative that can also stabilize heart rhythm) helps calm electrical storms—dangerous, repeated episodes of fast heartbeats. It is for people in the intensive care unit who are experiencing this emergency.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and in the intensive care unit for electrical storm (repeated episodes of a dangerously fast heart rhythm).
- You do not have ongoing shock that requires two or more blood-pressure-raising medicines for over 30 minutes (not caused by the abnormal heart rhythm).
- You have not had a cardiac arrest with more than 10 minutes of no blood flow or low blood flow before being enrolled.
- You are not having a heart attack (STEMI) with active signs of ongoing heart damage that caused the abnormal rhythm.
- You do not have a very slow heart rate (below 40 beats per minute) or a heart block without a pacemaker, and you are not pregnant or allergic to dexmedetomidine.
- You have not taken dexmedetomidine or clonidine in the 24 hours before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the long-term mental health of people who received a drug called dexmedetomidine during an electrical storm (a dangerous heart rhythm) in the ICU.
This study tests a combination of two medicines (dexmedetomidine and esketamine) to help ICU patients who are on a breathing machine feel calm and have less pain. The goal is to find a safe and effective way to keep patients comfortable while they recover.
This trial tests whether combining two sedative medications, esketamine and dexmedetomidine, is safer and more effective than using dexmedetomidine alone for treating hyperactive delirium in ICU patients who need breathing support. If you or a loved one are experiencing severe confusion and agitation while on a breathing machine, this study may offer a new treatment option.
This trial tests whether a sedating medicine called dexmedetomidine can reduce the risk of “delirium” (sudden confusion) in the intensive care unit after open-heart surgery. If you’re having certain heart operations, it may help protect your thinking and alertness during recovery.
This study tests whether a drug called dexmedetomidine (a sedative) can help calm patients with severe brain injury who are on a breathing machine in the intensive care unit. If you or your loved one is in this situation, this treatment might reduce agitation and improve recovery.
This study tests whether dexmedetomidine can protect the heart in people who are having a specific type of heart attack (anterior STEMI) when treated within 6 hours of symptom start. You may be considered if your diagnosis and vital signs fit the study safety rules, and if you can take part in follow-up.
Hear when a new Ventricular Tachycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.